Covered recipient · General Payments record
BRIAN J WELCH
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$12,739.87
- Reported across 668 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,299.56 | 141 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $294.36 | 20 |
| Novo Nordisk AS | $275.71 | 16 |
| Embecta Corp. | $199.15 | 12 |
| Abbott Laboratories | $183.25 | 16 |
| MannKind Corporation | $179.37 | 15 |
| IBSA Pharma Inc. | $144.16 | 8 |
| Corcept Therapeutics | $133.75 | 7 |
| Amgen Inc. | $100.39 | 5 |
| DEXCOM, INC. | $83.90 | 5 |
| Xeris Pharmaceuticals, Inc. | $79.08 | 4 |
| Insulet Corporation | $73.32 | 4 |
| PFIZER INC. | $60.71 | 3 |
| CeQur Corporation | $54.10 | 1 |
| Amneal Pharmaceuticals LLC | $51.99 | 3 |
| Antares Pharma, Inc. | $50.12 | 3 |
| Medtronic, Inc. | $45.18 | 3 |
| BETA BIONICS, INC. | $45.12 | 3 |
| SANOFI-AVENTIS U.S. LLC | $34.77 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.09 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.25 | 2 |
| Neurocrine BioSciences, Inc. | $27.58 | 1 |
| Acella Pharmaceuticals, LLC | $24.93 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $22.47 | 1 |
| ABBVIE INC. | $19.39 | 1 |
| Verity Pharmaceuticals Inc. | $18.47 | 1 |
| Alvogen Inc | $17.12 | 1 |
| Avvisto Therapeutics, LLC | $15.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (141)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.